Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2009
05/12/2009US7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells
05/12/2009US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis
05/12/2009US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence
05/12/2009US7531514 Orally administered peptides synergize statin activity
05/12/2009US7531512 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
05/12/2009US7531507 Such as 3-tert-Butyl-D-alanyl-3-(6-trifluoromethylpyridin-3-yl)-L-alanyl-de(1-D-leucyl-2-L-leucyl)-lysobactin bistrifluoroacetate; cell wall biosynthesis inhibitors; treatment and/or prophylaxis of bacterial infectious diseases
05/12/2009US7531506 Process for producing trunkamide a compounds
05/12/2009US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules
05/12/2009US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells
05/07/2009WO2009059011A2 Hla-dr binding peptides and their uses
05/07/2009WO2009059002A2 Macrocyclization of compounds from solid support using thioesterases
05/07/2009WO2009057982A1 Composition and method for preventing and treating immune-related disorder
05/07/2009WO2009057568A1 Polypeptide compound
05/07/2009WO2009056651A1 Angiotensin-carrier formulation
05/07/2009WO2009056631A2 Molecules and methods for modulating complement component
05/07/2009WO2009056342A1 Binding epitopes for g250 antibody
05/07/2009WO2007129999A3 Antiproliferative peptides and antibodies for their detection
05/07/2009WO2007008684A3 Ligands of melanocortin receptors
05/07/2009US20090119793 Plant Defense Signal Peptides
05/07/2009US20090119019 Small Molecule Mimetics of Erythropoietin
05/07/2009US20090118473 MN Gene and Protein
05/07/2009US20090118198 Novel peptide derivatives useful as antimicrobial agents for treating wounds
05/07/2009US20090118197 Immune-Modulating Peptide
05/07/2009US20090118195 Molecules Which Promote Hematopoiesis
05/07/2009US20090118193 Pegylated mutated clostridium botulinum toxin
05/07/2009US20090118191 Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF)
05/07/2009US20090118174 Novel peptides and methods for the treatment of inflammatory disorders
05/07/2009US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
05/07/2009US20090118169 Novel compounds and pharmaceutical use thereof
05/07/2009US20090118134 Template Fixed Beta-Hairpin Loop Mimetics and Their Use in Phage Display
05/07/2009US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis
05/07/2009US20090117150 Functional Mutations In Respiratory Syncytial Virus
05/07/2009US20090117140 Human papilloma virus dominant CD4 T cell epitopes and uses thereof
05/07/2009US20090117138 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
05/07/2009US20090117123 Immunopeptides of hpv e6 and e7 proteins
05/07/2009US20090117122 Resistin Antagonists and Their Use
05/07/2009US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427
05/07/2009US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization
05/07/2009US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer
05/07/2009DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier,
05/07/2009CA2704562A1 Polypeptide compound
05/07/2009CA2704397A1 Hla-dr binding peptides and their uses
05/07/2009CA2703911A1 Molecules and methods for modulating complement component
05/06/2009EP2056112A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
05/06/2009EP2055713A1 Peptide purification by means of metal ion affinity chromatography
05/06/2009EP2055712A1 Peptides and compounds that bind to a thrombopoietin receptor
05/06/2009EP1309336B1 Derivatives of laspartomycin and preparation and use thereof
05/06/2009CN101426809A Rubber composition containing organofunctional silanes
05/06/2009CN101426808A Novel protein transduction domains and uses therefor
05/06/2009CN101426807A Neuroprotective compounds and uses thereof
05/06/2009CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof
05/06/2009CN100484955C Analog of actinomycin D
05/05/2009US7528227 Histone H2A peptide derivatives and uses thereof
05/05/2009US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus
05/05/2009US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells
05/05/2009US7528112 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
05/05/2009US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/05/2009US7527792 Arg-arg-leu-ser-tyr-ser-arg-arg-arg-phe decapeptide bonded to drug such as doxorubicin via maleimide derivative linkage; preventing chemoresistance or drug resistance; gene expression inhibition of multidrug resistance gene
05/05/2009CA2234980C Cyclopeptide derivatives
04/2009
04/30/2009WO2009055005A2 Competitive inhibitors of invariant chain expression and/or ectopic clip binding
04/30/2009WO2009032978A3 Compositions and methods for diagnosing and treating urinary tract infections
04/30/2009WO2009026155A3 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates
04/30/2009WO2008157483A3 Polypeptides and methods of use
04/30/2009WO2008085794A3 Methods and compositions related to clot binding compounds
04/30/2009WO2007047764A3 Wt1 hla class ii-binding peptides and compositions and methods comprising same
04/30/2009WO2006081301A3 Plant defense signal peptides
04/30/2009WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling
04/30/2009US20090111756 Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus
04/30/2009US20090111755 Methods for the use of inhibitors of antigen presentation by mhc class ii molecules
04/30/2009US20090111753 Nogo-A Polypeptide Fragments, Variant Nogo Receptor-1 Polypeptides, and Uses Thereof
04/30/2009US20090111743 Cysteine-branched heparin-binding growth factor analogs
04/30/2009US20090111738 Fibronectin polypeptides and methods of use
04/30/2009US20090111737 Novel antibacterial agents
04/30/2009US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis
04/30/2009US20090111124 Kinase peptides and antibodies
04/30/2009US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation
04/30/2009US20090110662 Modification of biological targeting groups for the treatment of cancer
04/30/2009DE102008047781A1 Use of an oligopeptide comprising a specific amino acid-sequence for the diagnosis or therapy of a pathological condition in a mammal, preferably human, where the condition is identified by angiogenic processes
04/30/2009CA2703585A1 Competitive inhibitors of invariant chain expression and/or ectopic clip binding
04/30/2009CA2703482A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
04/29/2009EP2052253A2 Immunogenic compounds and protein mimics
04/29/2009EP2051992A1 Method for producing condensation products from n-substituted glycine derivatives (peptoids) by sequential ugi-multicomponent reactions
04/29/2009EP1487863B1 Process for purifying glycopeptide phospohonate derivatives
04/29/2009EP1423137B1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
04/29/2009EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
04/29/2009EP1115739B1 Auxiliary for amide bond formation
04/29/2009EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus
04/29/2009CN101421417A PCR hot start by magnesium sequestration
04/29/2009CN101421299A Peptide vaccine for inducing production of anti-amyloid- -peptide antibody
04/29/2009CN101421291A Process for the manufacture of lysobactin derivatives
04/29/2009CN101418271A Bacillus amyloliquefaciens producing lipopeptide to promote fungi apoptosis and lipopeptide prepared by the same and use
04/29/2009CN101418047A Antigen-antibody compound crystal and preparation method thereof and antigen epitope
04/29/2009CN101418039A Novel antibacterial peptide and preparation method and use thereof
04/29/2009CN101418038A Highland barley peptide and preparation method thereof
04/29/2009CN101418037A Yak bone peptide and preparation method thereof
04/29/2009CN101418036A Rapid purification of gamma trichosanthin and crystallization technology thereof
04/29/2009CN100482683C Active fragment of human glycine-rich protein and use thereof
04/29/2009CN100482682C Novel melanocortin receptor agonists
04/28/2009US7524926 Mucin hypersecretion inhibitors and methods of use
04/28/2009US7524820 Administering one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides, to inhibit neucrosis factor kappa Beta mediated inflammatory cytokine release